Cigna subsidiary Evernorth Health Services is expanding its coverage of NeuroStar Transcranial Magnetic Stimulation (TMS) to include adolescents aged 15 and older living with major depressive disorder, in
Dr. Peter Marks has resigned his position as director of the Center for Biologics Evaluation and Research at the Food and Drug Administration.
AI needs to be explainable as to its decision-making and healthcare organizations need to develop the framework for validation standards, says Mika Newton, CEO of xCures.